(Reuters) – The S&P 500 and Nasdaq opened at record levels on Monday after the U.S. health regulator approved the emergency use of blood plasma in COVID-19 patients and on report the Trump administration may fast-track a vaccine candidate. The S&P 500 opened higher by 20.93 points, or 0.62%, at 3,418.09. The Nasdaq Composite gained 137.45 points, or 1.22%, to 11,449.25 at the opening bell.
The Dow Jones Industrial Average rose 147.25 points, or 0.53%, at the open to 28,077.58.
(Reporting by Medha Singh in Bengaluru; Editing by Sriraj Kalluvila)
The post S&P 500, Nasdaq open at new highs on COVID-19 treatment hopes appeared first on Morningology.
